Science

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology

Perspectives on the role of Wnt biology in cancer

mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment

Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

Validation of a DKK1 in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors

DKK1 promotes tumor immune evasion and impedes anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer